Delphinus Medical Technologies, a Novi, Michigan-based medical imaging company, today announced the U.S. Food and Drug Administration has given its breast cancer-screening ultrasound device premarket approval.
The SoftVue 3D Whole Breast Ultrasound Tomography System is intended to be used in addition to digital mammograms to screen for breast cancer among patients with dense breast tissue....